Oral ponesimod in relapsing–remitting multiple sclerosis: a randomised phase II trial
Olsson, Tomas, Boster, Aaron, Fernández, Óscar, Freedman, Mark S, Pozzilli, Carlo, Bach, Doris, Berkani, Ouali, Mueller, Markus S, Sidorenko, Tatiana, Radue, Ernst-Wilhelm, Melanson, Maria
Published in Journal of neurology, neurosurgery and psychiatry (01.11.2014)
Published in Journal of neurology, neurosurgery and psychiatry (01.11.2014)
Get full text
Journal Article
Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases
Denton, C P, Pope, J E, Peter, H-H, Gabrielli, A, Boonstra, A, van den Hoogen, F H J, Riemekasten, G, De Vita, S, Morganti, A, Dölberg, M, Berkani, O, Guillevin, L
Published in Annals of the rheumatic diseases (01.09.2008)
Published in Annals of the rheumatic diseases (01.09.2008)
Get full text
Journal Article
POS1147 EFFICACY OF CENERIMOD IN PATIENTS WITH HIGH IFN-1 GENE EXPRESSION SIGNATURE AND HIGH ANTI-DSDNA ANTIBODY LEVELS: POST-HOC ANALYSIS FROM A PHASE 2 STUDY
Askanase, A, D D’cruz, Kalunian, K, Merrill, J, Navarra, S, Cahuzac, C, Cornelisse, P, Strasser, D, Trokan, L, Berkani, O
Published in Annals of the rheumatic diseases (01.06.2023)
Published in Annals of the rheumatic diseases (01.06.2023)
Get full text
Journal Article
Efficacy and safety of ponesimod, an oral, selective sphingosine 1-phosphate receptor-1 modulator, in patients with relapsing-remitting multiple sclerosis: results from a phase IIb, randomised, double-blind, placebo-controlled trial
Olsson, T, Boster, A, Fernandez, O, Freedman, MS, Pozzilli, C, Bach, D, Berkani, O, Mueller, M, Sidorenko, T, Melanson, M
Published in MULTIPLE SCLEROSIS JOURNAL (2012)
Get full text
Published in MULTIPLE SCLEROSIS JOURNAL (2012)
Conference Proceeding
Pharmacodynamic effect, safety and tolerability of ponesimod, a selective sphingosine 1-phosphate receptor-1 modulator, in patients with relapsing-remitting multiple sclerosis
Fernandez, O, Pozzilli, C, Freedman, MS, Olsson, T, Melanson, M, Bach, D, Berkani, O, Mueller, M, Sidorenko, T, Boster, A
Published in MULTIPLE SCLEROSIS JOURNAL (2012)
Get full text
Published in MULTIPLE SCLEROSIS JOURNAL (2012)
Conference Proceeding
Dose-dependent effect of ponesimod, an oral, selective sphingosine 1-phosphate receptor-1 modulator, on magnetic resonance imaging outcomes in patients with relapsing-remitting multiple sclerosis
Freedman, MS, Olsson, T, Melanson, M, Fernandez, O, Boster, A, Bach, D, Berkani, O, Mueller, M, Sidorenko, T, Pozzilli, C
Published in MULTIPLE SCLEROSIS JOURNAL (2012)
Get full text
Published in MULTIPLE SCLEROSIS JOURNAL (2012)
Conference Proceeding